According to Tongbi Finance, on June 2, 2026, Hangzhou Tigermed Consulting Co., Ltd. (stock abbreviation: Tigermed, code: 300347.SZ) received a Wind ESG rating of A. The company's overall score is 7.63, higher than the industry average of 6.67 in the Life Sciences Tools and Services III sector. It ranks 9th among 33 companies in the Life Sciences Tools and Services III sector, placing it in the top 27.27% of the industry. The scores for the environmental, social, and governance dimensions are 6.68, 7.48, and 7.15, respectively.

Compared to the previous rating, the overall score decreased from 8.33 to 7.63, a drop of 0.70 points. Specifically, the contribution from management practices fell from 5.34 to 5.09, a decrease of 0.25 points; the contribution from controversy events dropped from 2.98 to 2.54, a decline of 0.44 points. In terms of dimensions, the environmental score decreased by 1.43 points, the social score slightly increased by 0.03 points, and the governance score decreased by 0.61 points.

Rating Observation

In the environmental dimension, the company has established a relatively complete management system in the field of climate change and has promoted emission reduction through various measures. The board of directors, as the highest decision-making body, supervises the formulation of climate strategies and the setting of emission reduction targets, and promotes the verification of science-based targets initiative (SBTi) through compliance and ESG committees. During the reporting period, the company's total greenhouse gas emissions (Scope 1 and Scope 2) amounted to 14,866.95 tons of carbon dioxide equivalent, with Scope 2 emissions accounting for over 99%. In specific actions, the company has built a 93.6 kW distributed photovoltaic power generation system in its Hangzhou park, with an annual power generation of approximately 93.6 MWh, and prioritizes the use of environmentally friendly refrigerants and energy-efficient equipment in procurement to reduce energy consumption. In terms of waste management, some subsidiaries have obtained ISO 14001:2015 environmental management system certification and implement strict third-party compliance disposal for hazardous waste. However, information on waste recycling rates and management target planning has not been disclosed, indicating that there is still room for improvement in information completeness.

In the social dimension, the company demonstrates strong research and innovation capabilities and places a high emphasis on employee development and training. The company has obtained GB/T 29490-2023 intellectual property compliance management system certification and has established an intelligent research institute and an innovation expert committee to manage innovation projects and R&D resources comprehensively. During the reporting period, R&D investment accounted for 3.77% of revenue, with a total of 106 effective patents and 14.11 software copyrights per 100 million revenue. The company has also set a goal to operate 6 innovation projects annually and cultivate 10 new innovative talents, tracking progress through a regular review mechanism. In terms of employee development, the training coverage rate reached 100%, with an average training duration of 52.9 hours per person, and resources are integrated through an online learning platform to support employees' professional skill enhancement. However, the disclosure of information regarding assistance for struggling employees and equity incentives still needs improvement In terms of governance, the company demonstrates strong structural checks and balances in board independence and ESG governance mechanisms. The proportion of independent directors on the board is 42.86%, and no independent director has a tenure exceeding 6 years or 9 years, indicating a high level of independence. The company has established a Compliance and ESG Committee, chaired by a director who also serves as the general manager, and regularly reports ESG management progress to the board. Additionally, ESG performance is included in the executive compensation assessment, accounting for 20% of the overall annual performance compensation. The proportion of female executives is 60%, and the proportion of female directors is 28.57%, reflecting a certain degree of gender diversity. However, the overlap of members in the compensation committee and executive members may pose challenges to independence and deserves further attention.

Content generated by AI on June 3, 2026, please verify important information